Disc Medicine: Wedbush raises target price to $110 from $100
IRON•Wedbush raised its target price for Disc Medicine to $110 from $100.
Related News
Gartner target price raised to $235 from $205 by Truist Securities
IT•
Mexico revamps aviation regulator following US safety audit
AERO•
Brent hits five-month high as attacks on ships, Saudi sites fuel supply worries
USO•
Apple commits up to $100 million for US titanium in domestic manufacturing push
AAPL•
Regions Financial: Truist Securities cuts target price to $30 from $31
RF•